Intravesical Disitamab Vedotin (RC48) for HER2‐Expressing High‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Single‐Arm, Dose–Escalation Phase I Trial Study by Xu Chen, Ming Huang, Zehua Chen, Chengjunyu Zhang, Bolin Pan, Chu Liu, Wentong Xu, Jianmin Fang, Jian Huang, Tianxin Lin

Get full text

Trends and sex disparities in the burden of urolithiasis in 204 countries and territories, 1990–2021 by Junjiong Zheng, Qihang Zhang, Jie Zhang, Yuhui Yao, Li Chen, Yunfei Liu, Yi Song, Tianxin Lin, Guohua He, Sihan Zhou

Get full text

Adjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis. by Changhao Chen, Tianxin Lin, Yu Zhou, Doudou Li, Kewei Xu, Zhihua Li, Xinxiang Fan, Guangzheng Zhong, Wang He, Xu Chen, Xianyin He, Jian Huang

Get full text